Vanguard Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $26.8B | Buy |
254,322,763
+2,185,853
| +0.9% | +$205M | 0.39% | 34 |
|
|
2025
Q3 | $21.2B | Sell |
252,136,910
-777,516
| -0.3% | -$64M | 0.32% | 42 |
|
|
2025
Q2 | $20B | Buy |
252,914,426
+401,045
| +0.2% | +$31.9M | 0.32% | 43 |
|
|
2025
Q1 | $22.7B | Buy |
252,513,381
+1,417,274
| +0.6% | +$132M | 0.41% | 30 |
|
|
2024
Q4 | $25B | Buy |
251,096,107
+1,292,192
| +0.5% | +$133M | 0.44% | 27 |
|
|
2024
Q3 | $28.4B | Buy |
249,803,915
+5,126,701
| +2% | +$609M | 0.51% | 23 |
|
|
2024
Q2 | $30.3B | Buy |
244,677,214
+1,407,315
| +0.6% | +$181M | 0.58% | 21 |
|
|
2024
Q1 | $32.1B | Sell |
243,269,899
-1,506,848
| -0.6% | -$186M | 0.64% | 20 |
|
|
2023
Q4 | $26.7B | Buy |
244,776,747
+1,236,228
| +0.5% | +$128M | 0.58% | 20 |
|
|
2023
Q3 | $25.1B | Sell |
243,540,519
-99,634
| -0% | -$10.7M | 0.62% | 21 |
|
|
2023
Q2 | $28.1B | Sell |
243,640,153
-304,970
| -0.1% | -$34.6M | 0.67% | 20 |
|
|
2023
Q1 | $26B | Buy |
243,945,123
+16,739,145
| +7% | +$1.81B | 0.66% | 19 |
|
|
2022
Q4 | $25.2B | Buy |
227,205,978
+3,071,530
| +1% | +$314M | 0.69% | 21 |
|
|
2022
Q3 | $19.3B | Buy |
224,134,448
+3,081,402
| +1% | +$275M | 0.57% | 24 |
|
|
2022
Q2 | $20.2B | Buy |
221,053,046
+4,956,989
| +2% | +$439M | 0.57% | 24 |
|
|
2022
Q1 | $17.7B | Buy |
216,096,057
+4,893,526
| +2% | +$386M | 0.42% | 34 |
|
|
2021
Q4 | $16.2B | Buy |
211,202,531
+734,443
| +0.3% | +$58.5M | 0.37% | 46 |
|
|
2021
Q3 | $15.8B | Sell |
210,468,088
-15,085,702
| -7% | -$1.15B | 0.39% | 40 |
|
|
2021
Q2 | $17.5B | Sell |
225,553,790
-10,462,024
| -4% | -$778M | 0.44% | 31 |
|
|
2021
Q1 | $17.4B | Buy |
236,015,814
+17,601,459
| +8% | +$1.3B | 0.47% | 28 |
|
|
2020
Q4 | $17B | Sell |
218,414,355
-1,525,133
| -0.7% | -$117M | 0.49% | 27 |
|
|
2020
Q3 | $17.4B | Sell |
219,939,488
-3,058,864
| -1% | -$240M | 0.58% | 26 |
|
|
2020
Q2 | $16.5B | Sell |
222,998,352
-4,412,903
| -2% | -$332M | 0.58% | 23 |
|
|
2020
Q1 | $16.7B | Buy |
227,411,255
+6,762,890
| +3% | +$532M | 0.71% | 17 |
|
|
2019
Q4 | $19.1B | Buy |
220,648,365
+1,097,147
| +0.5% | +$90.1M | 0.65% | 21 |
|
|
2019
Q3 | $17.6B | Sell |
219,551,218
-10,834
| -0% | -$868K | 0.65% | 21 |
|
|
2019
Q2 | $17.6B | Buy |
219,562,052
+1,775,689
| +0.8% | +$136M | 0.66% | 21 |
|
|
2019
Q1 | $17.3B | Buy |
217,786,363
+2,324,282
| +1% | +$174M | 0.68% | 21 |
|
|
2018
Q4 | $15.7B | Buy |
215,462,081
+2,892,051
| +1% | +$204M | 0.71% | 19 |
|
|
2018
Q3 | $14.4B | Buy |
212,570,030
+969,087
| +0.5% | +$61.7M | 0.56% | 25 |
|
|
2018
Q2 | $12.3B | Buy |
211,600,943
+3,045,550
| +1% | +$172M | 0.51% | 27 |
|
|
2018
Q1 | $10.8B | Buy |
208,555,393
+1,610,007
| +0.8% | +$87M | 0.47% | 33 |
|
|
2017
Q4 | $11.1B | Buy |
206,945,386
+413,113
| +0.2% | +$22.9M | 0.49% | 32 |
|
|
2017
Q3 | $12.6B | Buy |
206,532,273
+3,069,029
| +2% | +$186M | 0.59% | 25 |
|
|
2017
Q2 | $12.4B | Buy |
203,463,244
+3,471,457
| +2% | +$211M | 0.61% | 21 |
|
|
2017
Q1 | $12.1B | Buy |
199,991,787
+6,395,122
| +3% | +$388M | 0.62% | 21 |
|
|
2016
Q4 | $10.9B | Buy |
193,596,665
+4,976,297
| +3% | +$291M | 0.61% | 22 |
|
|
2016
Q3 | $11.2B | Buy |
188,620,368
+5,409,329
| +3% | +$316M | 0.66% | 21 |
|
|
2016
Q2 | $10.1B | Buy |
183,211,039
+3,397,882
| +2% | +$181M | 0.63% | 21 |
|
|
2016
Q1 | $9.08B | Buy |
179,813,157
+4,139,843
| +2% | +$203M | 0.59% | 23 |
|
|
2015
Q4 | $8.85B | Buy |
175,673,314
+2,466,955
| +1% | +$124M | 0.6% | 25 |
|
|
2015
Q3 | $8.16B | Buy |
173,206,359
+1,412,430
| +0.8% | +$75M | 0.59% | 25 |
|
|
2015
Q2 | $9.33B | Buy |
171,793,929
+1,431,244
| +0.8% | +$80.3M | 0.63% | 21 |
|
|
2015
Q1 | $9.34B | Buy |
170,362,685
+7,183,684
| +4% | +$407M | 0.63% | 18 |
|
|
2014
Q4 | $8.84B | Buy |
163,179,001
+2,573,955
| +2% | +$143M | 0.64% | 18 |
|
|
2014
Q3 | $9.08B | Buy |
160,605,046
+2,743,901
| +2% | +$154M | 0.71% | 18 |
|
|
2014
Q2 | $8.71B | Buy |
157,861,145
+2,776,231
| +2% | +$151M | 0.69% | 17 |
|
|
2014
Q1 | $8.4B | Buy |
155,084,914
+4,795,589
| +3% | +$248M | 0.71% | 18 |
|
|
2013
Q4 | $7.18B | Buy |
150,289,325
+2,139,590
| +1% | +$97.8M | 0.63% | 19 |
|
|
2013
Q3 | $6.73B | Sell |
148,149,735
-1,651,686
| -1% | -$75.4M | 0.66% | 19 |
|
|
2013
Q2 | $6.64B | Buy |
+149,801,421
| New | +$6.69B | 0.7% | 19 |
|
Other funds holding MRK
Vanguard Group's MRK Position: Q4 2025 in Review
Vanguard Group increased its Merck (MRK) stake by 0.87% in Q4 2025, buying an estimated $205M and bringing the position to 254,322,763 shares worth $26.8B. The position accounts for 0.39% of the portfolio, ranked #34.
Vanguard Group first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $32.1B in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Vanguard Group held 254,322,763 shares of Merck worth $26.8B as of Q4 2025.
- Vanguard Group bought 2,185,853 Merck shares in Q4 2025, an estimated $205M.
- Merck made up 0.39% of Vanguard Group's portfolio in Q4 2025, its #34 holding.
- Vanguard Group first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Merck position peaked at $32.1B in Q1 2024.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.